Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexidol in Ischemic Stroke
NCT07575984Phase 4Recruiting
- Sponsor
- Pharmasoft
- Start
- Nov 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emoxypine in ischemic stroke, sponsored by Pharmasoft. Started Nov 2025; status: recruiting.
02
Drugs
emoxypine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07575984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07575984.